Page 10 - Accomplishments Dr. Sinnott and Dr. Oxner Revised Table_Classical
P. 10
RESEARCH
Approved Active Studies
Project Title Faculty Roles Deliverable Products Scheduled Workgroup Total Hours
Meetings on Project
(start/completion)
Drug: Emergency use, Remdesivir
- For the Treatment of Selected
Coronavirus (CoV) Infection
Device: 3D Swabs
Regeneron – Assessing Efficacy
and Safety of Sarilumab for
Hospitalized Patients with
COVID-19
Drug: Hydroxychloroquine for
SARS-CoV - The purpose of this
study is to assess the benefits to
health outcomes of administering
hydroxychloroquine vs. placebo in
outpatients with confirmed SARS-
CoV-2.
9
